granted
on 02 Jul 2024
Last Applicant/ Owned by
150 CambridgePark Drive, 9th Floor
Cambridge
MA
02140
Serial Number
90828261 filed on 14th Jul 2021
Registration Number
N/A
Correspondent Address
John V. Hobgood, Esquire
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Scientific research; Pharmaceutical research; Medical research; Engineering of biological cells; genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; Pharmaceu Read More
Scientific research; Pharmaceutical research; Medical research; Engineering of biological cells; genetic engineering of biological cells; Technological consultation services in the fields of engineering of biological cells; Laboratory research services in the field of immunology and cellular engineering
N/A
N/A
Gene therapy products, namely, engineered cell platforms for immunotherapy purposes; Pharmaceutical preparations for use in the treatment of autoimmune diseases and disorders, autoinflammatory diseases and disorders, alloimmune diseases and disorders and allergic diseases and disorders
N/A
N/A
Custom manufacture of pharmaceuticals for others; Custom manufacturing of biological cells; consultation in the field of custom manufacture of pharmaceuticals and biological cells
N/A
N/A
No 90828261
No Service Mark
No 2217678.121
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
03rd Jul 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
03rd Jul 2024 | SOU EXTENSION 3 GRANTED |
03rd Jul 2024 | SOU EXTENSION 3 FILED |
02th Jul 2024 | SOU TEAS EXTENSION RECEIVED |
12th Jan 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
10th Jan 2024 | SOU EXTENSION 2 GRANTED |
10th Jan 2024 | SOU TEAS EXTENSION RECEIVED |
10th Jan 2024 | SOU EXTENSION 2 FILED |
12th Jul 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
10th Jul 2023 | SOU EXTENSION 1 GRANTED |